6 Reasons to Invest in Medicure

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.

Learn More

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

At Medicure, we are focused on improving the health of patients by offering a growing portfolio of products and services and ensuring all patients get access to care they need.

Our Products

Press Releases

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2024

November 25, 2024

MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 26, 2024 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2024 AND ANNOUNCES RESIGNATION OF BOARD MEMBER

November 18, 2024

MEDICURE ANNOUNCES POSITIVE SETTLEMENT OF PRODUCT DEVELOPMENT AND SUPPLY CONTRACTS

October 24, 2024

More Press Releases

RMedicureDirect ^ * ) &

Medicure Inc.

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2024

A conference call will be held Tuesday, November 26, 2024 at 7:30am CT (8:30 ET)

See Press Release
End of an Era?
Big Chain Pharmacies
Close as New Players
Like Marley Drug Step In.

Read More
2024 PARIS MEDALIST!

Congratulations to Medicure's Leanne Taylor!

Leanne's Journey
Our Mission

We Bring Medicine to Life

At Medicure, our mission is to serve patients by delivering safe and efficacious life-changing medicines

Learn More
MEDICURE ANNOUNCES CLOSING OF ASSET PURCHASE AGREEMENT WITH CANAM BIORESEARCH FOR ACQUISITION OF INTELLECTUAL PROPERTY

See Press Release
Medicure announces new partnership through it's Marley Drug subsidiary to provide Brenzavvy® as an affordable medication for americans with Type 2 Diabetes

See Press Release
Celebrating Our Recognition as One of the Best Places to Work in 2024!

News and Media
Research and Products

FDA Provides Complete Approval to Enroll Patients in its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

Medicure's Phase 3 clinical trial aims to evaluate the use of its investigational product MC-1 for treatment of a rare pediatric disease called pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency.

Learn More
Interview on Medicure's 25th Anniversary with CEO, Dr. Albert Friesen

Read More
Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Medicure Inc.– via Marley Drug, creates a direct-to-consumer e-commerce pharmacy solution. The service is available in all 50 states and can fulfill a formulary of over 100 prescription medications.

Learn More
Lipid management is important for heart health

At Medicure, we are focused on improving the heart health of patients by delivering safe and efficacious cardiovascular medicines and ensuring all patients get access to therapy.

Learn More
News and Media

Antiplatelet therapy in the management of stroke patients

Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial in Patients with Aneurysmal Subarachnoid Hemorrhage

Learn More

Stay Connected

Sign up for our newsletter

#PageBgImage{opacity:0}.fancybox-custom .fancybox-skin{box-shadow:0 0 50px #222}.fancybox-nav{width:60px}.fancybox-nav span{visibility:visible;opacity:1}.fancybox-nav:hover span{opacity:.7}.fancybox-next{right:-80px}.fancybox-prev{left:-80px}html{scroll-behavior:smooth}.bg-padding-top{padding-top:100px!important}.content_container_external_home_mobile.bg-padding-top,.content_container_external_mobile.bg-padding-top,.content_container_external_home_mobile .bg-padding-top,.content_container_external_mobile .bg-padding-top{padding-top:30px!important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed,.content_container_external .content_full .narrow_content iframe.youtube_embed{height: calc(720px * 9 / 16) !important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts{height: calc(720px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_75 iframe.youtube_embed,.content_container_external .content_full .tile_size_75 iframe.youtube_embed{height: calc(860px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_75 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_75 iframe.youtube_embed.youtube_embed_shorts{height: calc(860px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_66 iframe.youtube_embed,.content_container_external .content_full .tile_size_66 iframe.youtube_embed{height: calc(780px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_66 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_66 iframe.youtube_embed.youtube_embed_shorts{height: calc(780px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_50 iframe.youtube_embed,.content_container_external .content_full .tile_size_50 iframe.youtube_embed{height: calc(550px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_50 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_50 iframe.youtube_embed.youtube_embed_shorts{height: calc(550px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_33 iframe.youtube_embed,.content_container_external .content_full .tile_size_33 iframe.youtube_embed{height: calc(360px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_33 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_33 iframe.youtube_embed.youtube_embed_shorts{height: calc(360px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_25 iframe.youtube_embed,.content_container_external .content_full .tile_size_25 iframe.youtube_embed{height: calc(237px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_25 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_25 iframe.youtube_embed.youtube_embed_shorts{height: calc(237px * 16 / 9) !important}.content_container_external_home .content_full .tile_size_20 iframe.youtube_embed,.content_container_external .content_full .tile_size_20 iframe.youtube_embed{height: calc(224px * 9 / 16) !important}.content_container_external_home .content_full .tile_size_20 iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .tile_size_20 iframe.youtube_embed.youtube_embed_shorts{height: calc(224px * 16 / 9) !important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed,.content_container_external .content_full .narrow_content iframe.youtube_embed{height: calc(720px * 9 / 16) !important}.content_container_external_home .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts,.content_container_external .content_full .narrow_content iframe.youtube_embed.youtube_embed_shorts{height: calc(720px * 16 / 9) !important}#PageBgImage{opacity:0;transition:opacity 500ms;-moz-transition:opacity 500ms;-webkit-transition:opacity 500ms;-o-transition:opacity 500ms}.banner .banner_overlay .more>a{pointer-events:all}#bannerRotator ul li{-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover}#header_container,.banner{height:0}#header_container,.banner,.banner>#bannerRotator>ul>li,.banner>#bannerRotator>ul>li>img,.banner>#bannerRotator>ul>li>a>img{transition:height 500ms;-moz-transition:height 500ms;-webkit-transition:height 500ms;-o-transition:height 500ms}#content_container{margin-top:0;transition:margin 500ms;-moz-transition:margin 500ms;-webkit-transition:margin 500ms;-o-transition:margin 500ms}

6 Reasons to Invest in Medicure

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

Press Releases

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2024

MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 26, 2024 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2024 AND ANNOUNCES RESIGNATION OF BOARD MEMBER

MEDICURE ANNOUNCES POSITIVE SETTLEMENT OF PRODUCT DEVELOPMENT AND SUPPLY CONTRACTS

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2024

End of an Era?
Big Chain Pharmacies
Close as New Players
Like Marley Drug Step In.

2024 PARIS MEDALIST!

Congratulations to Medicure's Leanne Taylor!

Our Mission

We Bring Medicine to Life

MEDICURE ANNOUNCES CLOSING OF ASSET PURCHASE AGREEMENT WITH CANAM BIORESEARCH FOR ACQUISITION OF INTELLECTUAL PROPERTY

Medicure announces new partnership through it's Marley Drug subsidiary to provide Brenzavvy® as an affordable medication for americans with Type 2 Diabetes

Celebrating Our Recognition as One of the Best Places to Work in 2024!

Research and Products

FDA Provides Complete Approval to Enroll Patients in its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

Interview on Medicure's 25th Anniversary with CEO, Dr. Albert Friesen

Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Lipid management is important for heart health

News and Media

Antiplatelet therapy in the management of stroke patients

Stay Connected

Sign up for our newsletter

About

Products

News and Media

Investors

Online Pharmacy

Contact Us

6 Reasons to Invest in Medicure

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

Press Releases

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2024

MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 26, 2024 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2024 AND ANNOUNCES RESIGNATION OF BOARD MEMBER

MEDICURE ANNOUNCES POSITIVE SETTLEMENT OF PRODUCT DEVELOPMENT AND SUPPLY CONTRACTS

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2024

End of an Era?Big Chain PharmaciesClose as New PlayersLike Marley Drug Step In.

2024 PARIS MEDALIST!

Congratulations to Medicure's Leanne Taylor!

Our Mission

We Bring Medicine to Life

MEDICURE ANNOUNCES CLOSING OF ASSET PURCHASE AGREEMENT WITH CANAM BIORESEARCH FOR ACQUISITION OF INTELLECTUAL PROPERTY

Medicure announces new partnership through it's Marley Drug subsidiary to provide Brenzavvy® as an affordable medication for americans with Type 2 Diabetes

Celebrating Our Recognition as One of the Best Places to Work in 2024!

Research and Products

FDA Provides Complete Approval to Enroll Patients in its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease

Interview on Medicure's 25th Anniversary with CEO, Dr. Albert Friesen

Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Lipid management is important for heart health

News and Media

Antiplatelet therapy in the management of stroke patients

Stay Connected

Sign up for our newsletter

About

Products

News and Media

Investors

Online Pharmacy

Contact Us

End of an Era?
Big Chain Pharmacies
Close as New Players
Like Marley Drug Step In.